A network map of aging finds drug candidates
Aging is not a single process but an interconnected web of molecular changes. A new framework maps that web and uses it to identify existing drugs that could target multiple aging processes at once.
Why is aging so hard to treat? A key reason is that the changes that accumulate with age are not isolated failures but deeply interwoven mechanisms. A protein that misfunctions affects a signalling pathway, which in turn alters other processes. Targeting one step may miss the broader picture.
Researchers publishing in Nature Aging introduced a network medicine framework. They mapped 2,358 genes associated with aging onto the human interactome, the full network of protein interactions in the human body. Their finding: the established hallmarks of aging, the fourteen recognised characteristics of biological aging, each form a connected cluster of genes within that network. The team called these hallmark modules.
How the framework works
By measuring the network distance of 6,442 existing compounds to each hallmark module, the researchers could estimate which substances might influence which aging hallmarks. They added a second metric called pAGE, which assesses how strongly a compound shifts gene activity within a given module in a direction opposite to known aging-related changes.
Combining network proximity and pAGE produced a ranked list of drug-repurposing candidates, each linked to specific aging hallmarks and interpretable molecular mechanisms. That interpretability is an advantage over purely statistical screening methods, which often produce candidates without a clear biological rationale.
Promises and limitations
This is a selection framework, not a proof of efficacy. The candidate drugs were identified through computational models and gene expression data. Whether they actually slow aging in humans remains to be tested. Drug repurposing, the strategy of finding new uses for approved medicines, is practically appealing but rarely produces large effect sizes.
From a longevity science perspective, the demonstration that aging hallmarks form a true molecular network is significant. It opens the possibility of targeting multiple aging processes simultaneously with a single compound, something that conventional single-target approaches struggle to achieve.
Want to research this yourself?
Search for example:
- network medicine aging interactome
- drug repurposing hallmarks of aging
- gene expression aging module